GlassScriptPhysician profile
Pavan Vabilisetti Murty
NPI 1710249503
$3,480.58
in general payments reported to CMS, 2019-2025
15 companies · $51.69 in 2025
The $51.69 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,811 · 2020: $278 · 2021: $571 · 2022: $191 · 2023: $322 · 2024: $256 · 2025: $51.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,947.50 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $306.01 | 2019-2024 | Briviact |
| Genzyme Corporation | $258.71 | 2019 | |
| Mallinckrodt Hospital Products INC. | $238.19 | 2021-2024 | Acthar |
| Lilly USA, LLC | $181.08 | 2019 | |
| Medical Device Business Services, INC. | $139.34 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $120.12 | 2019 | |
| Abbott Laboratories | $86.53 | 2019 | |
| Novartis Pharmaceuticals Corporation | $62.65 | 2019 | |
| Jazz Pharmaceuticals INC. | $36.11 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $27.83 | 2019 | |
| Pfizer INC. | $22.89 | 2024 | |
| Supernus Pharmaceuticals, INC. | $19.71 | 2019 | |
| Emd Serono, INC. | $17.47 | 2019 | |
| Genentech, INC. | $16.44 | 2023 | Tnkase |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pavan Murty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.